The evolution of bladder cancer genomics: What have we learned and how can we use it?-Reference-Cited by-同舟云学术

The evolution of bladder cancer genomics: What have we learned and how can we use it?

Published:2018-07 Issue:7 Volume:36 Page:313-320
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Audenet François,Attalla Kyrollis,Sfakianos John P.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference60 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Invasive bladder cancer: genomic insights and therapeutic promise;Kim;Clin Cancer Res,2015

3. Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases;Jewett;J Urol,1946

4. Carcinoma, carcinoma in situ, and “early lesions” of the uterine cervix and the urinary bladder: introduction and definitions;Friedell;Cancer Res,1976

5. Bladder cancer;Droller;Curr Probl Surg,1981

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing bladder cancer management: development of a prognostic model and personalized therapy;Frontiers in Immunology;2024-07-22

2. Exploring racial disparities in bladder urothelial cancer: insights into survival and genetic variations;African Journal of Urology;2024-05-21

3. GraphPath: a graph attention model for molecular stratification with interpretability based on the pathway–pathway interaction network;Bioinformatics;2024-03-26

4. Arab world’s impact on bladder cancer research and opportunities for growth: A bibliometric review study;Medicine;2024-03-22

5. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem‐immunoreceptor tyrosine‐based activation motif;Pathology International;2024-03-19